Pilot Study Evaluating the Safety and Efficacy of a New Hard-on-Hard Total Hip Replacement System (NCT02154516) | Clinical Trial Compass
CompletedNot Applicable
Pilot Study Evaluating the Safety and Efficacy of a New Hard-on-Hard Total Hip Replacement System
South Africa26 participantsStarted 2011-11-04
Plain-language summary
The purpose of this study is to assess the early and long term safety and efficacy of the hard-on-hard total hip replacement system (R3 ODH-ODH utilization) in patients with non-inflammatory arthritis.
Who can participate
Age range21 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* At least 21 years old
* Skeletally mature
* Requires primary, unilateral total hip arthroplasty due to degenerative join disease
* Preoperative Harris Hip Score of less than or equal to 70
* Meets an acceptable preoperative medical clearance and is free or treated for conditions that would pose excessive operative risk
* Given consent to participate in the study
* Able to understand the purpose of the study, his/her role, and is available for follow-up
10 year extension:
* Subject has completed the 2 year primary study
* Subject has signed an Independent Ethics Committee (IEC) approved Informed Consent Form agreeing to participate in the extension study after the nature, scope and possible consequences of the study have been explained in an understandable form
* Subject is able to fully understand the purpose of the study, his/her role as a participant in the study, and plans to be available through ten years post-operative follow-up
Exclusion Criteria:
* Diagnosis with high risk of Total Hip Arthroplasty (THA) failure
* Requires bilateral THA
* Requires revision of a prior hip replacement
* Active infection or sepsis
* History of local hip infection
* Known metastatic or neoplastic disease
* Conditions that may interfere with THA survival or outcomes
* Need for structural bone grafts to support the implant
* Contralateral lower extremity condition
* Has other joint replacements or plans for other joint replacements within 2 years
* Systemic …
What they're measuring
1
Number of Participants With Device-Related Revisions
Timeframe: Postoperatively through 10 years
2
Metal Ion Concentration in Whole Blood
Timeframe: 3 months, 6 months, 1 year, 2 years, 5 years, 7 years and 10 years post-operatively.